An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial

Study limitation reported by the research below: “The FACT-P minimally important clinical difference threshold is not stated in the abstract; clinicians should interpret the 4.5-point improvement in that context.”